← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Blackthorn Therapeutics, Inc.
San Francisco, CA
$1,617,097
Total funding
1
Grants
Funding over time
peak $1.2M · FY2017–20$2M$1.5M$1M$500K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$1,617,097 · 1
By mechanism
UH3$1,617,097 · 1
Investigators at Blackthorn Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Discovery of non-addictive KOR antagonists for migraine prophylaxis$1,236,992
UH3 · FY2017 · NS
Discovery of non-addictive KOR antagonists for migraine prophylaxis$139,735
UH3 · FY2019 · NS
Discovery of non-addictive KOR antagonists for migraine prophylaxis$129,735
UH3 · FY2018 · NS
Discovery of non-addictive KOR antagonists for migraine prophylaxis$110,635
UH3 · FY2020 · NS